ADMA logo

ADMA Biologics (ADMA) Long term liabilities

Annual long term liabilities:

$84.12M-$60.05M(-41.65%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ADMA annual total long term liabilities is $84.12 million, with the most recent change of -$60.05 million (-41.65%) on December 31, 2024.
  • During the last 3 years, ADMA annual long term liabilities has fallen by -$20.58 million (-19.66%).
  • ADMA annual long term liabilities is now -46.50% below its all-time high of $157.22 million, reached on December 31, 2022.

Performance

ADMA Long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADMAbalance sheet metrics

quarterly long term liabilities:

$83.65M-$466.00K(-0.55%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ADMA quarterly total long term liabilities is $83.65 million, with the most recent change of -$466.00 thousand (-0.55%) on March 31, 2025.
  • Over the past year, ADMA quarterly long term liabilities has dropped by -$60.43 million (-41.94%).
  • ADMA quarterly long term liabilities is now -47.19% below its all-time high of $158.41 million, reached on March 31, 2023.

Performance

ADMA quarterly long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherADMAbalance sheet metrics

Long term liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

ADMA Long term liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-41.6%-41.9%
3 y3 years-19.7%-44.1%
5 y5 years-3.2%-16.6%

ADMA Long term liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-46.5%at low-47.2%at low
5 y5-year-46.5%at low-47.2%at low
alltimeall time-46.5%>+9999.0%-47.2%>+9999.0%

ADMA Long term liabilities History

DateAnnualQuarterly
Mar 2025
-
$83.65M(-0.6%)
Dec 2024
$84.12M(-41.7%)
$84.12M(-26.1%)
Sep 2024
-
$113.84M(-20.9%)
Jun 2024
-
$143.95M(-0.1%)
Mar 2024
-
$144.08M(-0.1%)
Dec 2023
$144.17M(-8.3%)
$144.17M(-7.4%)
Sep 2023
-
$155.72M(+0.9%)
Jun 2023
-
$154.31M(-2.6%)
Mar 2023
-
$158.41M(+0.8%)
Dec 2022
$157.22M(+50.2%)
$157.22M(+1.0%)
Sep 2022
-
$155.73M(+0.8%)
Jun 2022
-
$154.46M(+3.3%)
Mar 2022
-
$149.53M(+42.8%)
Dec 2021
$104.70M(+5.3%)
$104.70M(+1.1%)
Sep 2021
-
$103.52M(+0.5%)
Jun 2021
-
$103.03M(+1.1%)
Mar 2021
-
$101.96M(+2.5%)
Dec 2020
$99.48M(+14.5%)
$99.48M(-2.6%)
Sep 2020
-
$102.13M(+0.3%)
Jun 2020
-
$101.78M(+1.5%)
Mar 2020
-
$100.28M(+15.4%)
Dec 2019
$86.87M(+46.0%)
$86.87M(+0.4%)
Sep 2019
-
$86.51M(+0.3%)
Jun 2019
-
$86.24M(+44.4%)
Mar 2019
-
$59.74M(+0.4%)
Dec 2018
$59.48M(+2.1%)
$59.48M(+0.4%)
Sep 2018
-
$59.25M(+0.3%)
Jun 2018
-
$59.08M(+0.7%)
Mar 2018
-
$58.67M(+0.7%)
Dec 2017
$58.25M
$58.25M(+25.3%)
DateAnnualQuarterly
Sep 2017
-
$46.48M(+12.5%)
Jun 2017
-
$41.31M(+168.3%)
Mar 2017
-
$15.40M(-9.0%)
Dec 2016
$16.92M(-9.4%)
$16.92M(-8.2%)
Sep 2016
-
$18.44M(-18.9%)
Jun 2016
-
$22.74M(+21.2%)
Mar 2016
-
$18.76M(+0.5%)
Dec 2015
$18.68M(+11.1%)
$18.68M(+0.4%)
Sep 2015
-
$18.61M(+9.0%)
Jun 2015
-
$17.08M(+2.2%)
Mar 2015
-
$16.71M(-0.6%)
Dec 2014
$16.82M(+149.2%)
$16.82M(+41.0%)
Sep 2014
-
$11.92M(+1.2%)
Jun 2014
-
$11.78M(+0.3%)
Mar 2014
-
$11.74M(+74.0%)
Dec 2013
$6.75M(+56.4%)
$6.75M(-2.5%)
Sep 2013
-
$6.92M(-0.2%)
Jun 2013
-
$6.93M(+30.4%)
Mar 2013
-
$5.32M(+23.2%)
Dec 2012
$4.31M(>+9900.0%)
$4.31M(+1913.3%)
Sep 2012
-
$214.30K(-3.7%)
Jun 2012
-
$222.50K(-3.6%)
Mar 2012
-
$230.90K(>+9900.0%)
Dec 2011
-
$0.00(0.0%)
Sep 2011
-
$0.00(0.0%)
Jun 2011
$0.00(0.0%)
$0.00(0.0%)
Mar 2011
-
$0.00(0.0%)
Dec 2010
-
$0.00(0.0%)
Jun 2010
-
$0.00
Jun 2010
$0.00
-

FAQ

  • What is ADMA Biologics annual total long term liabilities?
  • What is the all time high annual long term liabilities for ADMA Biologics?
  • What is ADMA Biologics annual long term liabilities year-on-year change?
  • What is ADMA Biologics quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for ADMA Biologics?
  • What is ADMA Biologics quarterly long term liabilities year-on-year change?

What is ADMA Biologics annual total long term liabilities?

The current annual long term liabilities of ADMA is $84.12M

What is the all time high annual long term liabilities for ADMA Biologics?

ADMA Biologics all-time high annual total long term liabilities is $157.22M

What is ADMA Biologics annual long term liabilities year-on-year change?

Over the past year, ADMA annual total long term liabilities has changed by -$60.05M (-41.65%)

What is ADMA Biologics quarterly total long term liabilities?

The current quarterly long term liabilities of ADMA is $83.65M

What is the all time high quarterly long term liabilities for ADMA Biologics?

ADMA Biologics all-time high quarterly total long term liabilities is $158.41M

What is ADMA Biologics quarterly long term liabilities year-on-year change?

Over the past year, ADMA quarterly total long term liabilities has changed by -$60.43M (-41.94%)
On this page